Interim study to examine the role of a pharmacy benefit manager within the Nebraska health insurance industry and the impact on prescription drug prices

This resolution (LR 124) directs Nebraska's Banking, Commerce and Insurance Committee to conduct an interim study on pharmacy benefit managers (PBMs). The study will examine how PBMs operate within health insurance plans - including their pricing models, formulary management, and impact on prescription drug costs - and assess their effects on patient access and independent pharmacies. It specifically aims to evaluate PBM transparency and accountability, focusing on issues like spread pricing, rebates, and prior authorization practices. The study does not create new laws but will identify potential policy solutions to address rising drug costs affecting Nebraska residents and businesses. The committee is required to report findings and recommendations to the Legislature after completing the study.